Peptron, Inc. (KOSDAQ:087010)
242,000
+9,000 (3.86%)
Jan 19, 2026, 3:30 PM KST
Peptron Market Cap
Peptron has a market cap or net worth of 5.64 trillion as of January 16, 2026. Its market cap has increased by 129.80% in one year.
Market Cap
5.64T
Enterprise Value
5.57T
Revenue
6.19B
Ranking
n/a
PE Ratio
n/a
Stock Price
242,000.00
Market Cap Chart
Since July 22, 2015, Peptron's market cap has increased from 211.83B to 5.64T, an increase of 2,563.87%. That is a compound annual growth rate of 36.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 5.43T | -8.27% |
| Dec 30, 2025 | 5.92T | 149.72% |
| Dec 30, 2024 | 2.37T | 185.66% |
| Dec 28, 2023 | 830.23B | 426.14% |
| Dec 29, 2022 | 157.80B | -31.08% |
| Dec 30, 2021 | 228.96B | -8.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 88.92T |
| Celltrion | 45.73T |
| ALTEOGEN | 26.53T |
| ABL Bio | 10.89T |
| SK Biopharmaceuticals | 9.26T |
| Yuhan | 7.91T |
| HLB Co., Ltd. | 6.97T |
| Sam Chun Dang Pharm. | 6.49T |